UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 235

Sortiert nach

Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms

International journal of hematology, 2017-10, Vol.106 (4), p.517-521

2017

Volltextzugriff (PDF)

Leukemic blasts in transformed JAK2-V617F–positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation

Blood, 2007-07, Vol.110 (1), p.375-379

2007

Volltextzugriff (PDF)

A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology

Research and practice in thrombosis and haemostasis, 2024-07, Vol.8 (5), p.102516, Article 102516

2024

Volltextzugriff (PDF)

Splicing Anomalies in Myeloproliferative Neoplasms: Paving the Way for New Therapeutic Venues

Cancers, 2020-08, Vol.12 (8), p.2216

2020

Volltextzugriff (PDF)

Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells

Blood, 2011-08, Vol.118 (8), p.2211-2221

2011

Volltextzugriff (PDF)

Molecular diagnostics of myeloproliferative neoplasms

European journal of haematology, 2015-10, Vol.95 (4), p.270-279

2015

Volltextzugriff (PDF)

Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy

Haematologica (Roma), 2014-03, Vol.99 (3), p.458

2014

Volltextzugriff (PDF)

Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms

Platelets (Edinburgh), 2018-10, Vol.29 (7), p.723-728

2018

Volltextzugriff (PDF)

Human Cancer-Associated Mutations of SF3B1 Lead to a Splicing Modification of Its Own RNA

Cancers, 2020-03, Vol.12 (3), p.652

2020

Volltextzugriff (PDF)

Comparison of four methods to assess high-on platelet reactivity under P2Y12 receptor inhibitor

Platelets (Edinburgh), 2018-04, Vol.29 (3), p.1-264

2018

Volltextzugriff (PDF)

Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1β and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms

Cancers, 2020-08, Vol.12 (9), p.2446

2020

Volltextzugriff (PDF)

Absence of CALR mutations in JAK2-negative polycythemia

Haematologica (Roma), 2017-01, Vol.102 (1), p.e15

2017

Volltextzugriff (PDF)

Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants

Blood, 2011-05, Vol.117 (21), p.5719-5722

2011

Volltextzugriff (PDF)

MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms

BMC cancer, 2018-11, Vol.18 (1), p.1098-1098, Article 1098

2018

Volltextzugriff (PDF)

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

Blood, 2008-09, Vol.112 (6), p.2429-2438

2008

Volltextzugriff (PDF)

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis

Haematologica (Roma), 2014-07, Vol.99 (7), p.e98

2014

Volltextzugriff (PDF)

STAT1 activation in association with JAK2 exon 12 mutations

Haematologica (Roma), 2016-01, Vol.101 (1), p.e15

2016

Volltextzugriff (PDF)

Targeted High‐throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France

HemaSphere, 2023-09, Vol.7 (9), p.e943-n/a

2023

Volltextzugriff (PDF)

1 – 25 von 235

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(218)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(123)
Life Sciences & Biomedicine
(115)
Humans
(105)
Hematology
(75)
Life Sciences
(56)
Male
(56)
Female
(55)
Middle Aged
(43)
Aged
(40)
Oncology
(38)
Adult
(35)
Mutation
(33)
Janus Kinase 2 - Genetics
(28)
Aged, 80 And Over
(24)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Cancer
(21)
Human Health And Pathology
(19)
Adolescent
(18)
Hematologic And Hematopoietic Diseases
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(53)
Haematologica
(13)
British Journal Of Haematology
(10)
Annals Of Hematology
(9)
Hématologie
(7)
Leukemia & Lymphoma
(7)
Cancers
(6)
The Journal Of Molecular Diagnostics : Jmd
(6)
American Journal Of Hematology
(5)
Thrombosis Research
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms

Leukemic blasts in transformed JAK2-V617F–positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation

Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study

A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology

Splicing Anomalies in Myeloproliferative Neoplasms: Paving the Way for New Therapeutic Venues

Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells

Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study

Molecular diagnostics of myeloproliferative neoplasms

Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy

Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms

Human Cancer-Associated Mutations of SF3B1 Lead to a Splicing Modification of Its Own RNA

Comparison of four methods to assess high-on platelet reactivity under P2Y12 receptor inhibitor

Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation

Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1β and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms

The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis

Absence of CALR mutations in JAK2-negative polycythemia

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study

Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants

MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis

STAT1 activation in association with JAK2 exon 12 mutations

Targeted High‐throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France

The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated Degradation

Suchergebnisse filtern